Patents
Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
02/2010
02/04/2010US20100029639 Ion channel modulating compounds and uses thereof
02/04/2010US20100025661 Luminescent material and organic electroluminescent device using the same
02/04/2010CA2732403A1 System and method for removing hydrogen sulfide from a natural gas stream
02/04/2010CA2732282A1 Aminopropylidene derivative
02/04/2010CA2731198A1 Fungicide n-cycloalkyl-n-biphenylmethyl-carboxamide derivatives
02/03/2010EP2149549A1 Pharmaceutical composition for prevention or treatment of hepatitis
02/03/2010CN100586927C Amide derivatives and their use as inhibitors of 11-beta-hydroxysteroid dehydrogenase
02/02/2010US7655807 Low molecular weight conjugated nitrogen compounds and devices fabricated using the same
02/02/2010US7655641 3-(4-{2-[(5-Fluoro-3- methyl-benzo[b]thiophene-2- sulfonyl)-propyl- amino]-ethylsulfanyl}- 2-methyl-phenyl)- propionic acid; peroxisome proliferator activated receptor (PPAR); syndrome X, type II diabetes, hyperglycemia, hyperlipidemia, obesity, hypertension, arteriosclerosis and cardiovascular diseases
02/02/2010CA2559571C Method of preparing thieno[3,2-c]pyridine derivatives and intermediates used therein
02/02/2010CA2434162C Reaction method utilizing diaphram type catalyst and apparatus therefor
02/02/2010CA2294809C Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and compositions containing same
01/2010
01/28/2010WO2010011853A2 Beta-and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
01/28/2010WO2010011570A1 Adamantyl diamide derivatives and uses of same
01/28/2010WO2010009508A1 Antiparasitic compounds
01/28/2010WO2008137816A8 Tricyclic compounds as matrix metalloproteinase inhibitors
01/28/2010US20100022605 N-hydroxyamide derivatives possessing antibacterial activity
01/28/2010US20100022601 Sulfonamide compounds and the use
01/28/2010US20100022594 thiophene sulfonamide derivatives such as 5-Chloro-N-[(S)-2-hydroxy-1-phenylethyl]thiophene-2-sulfonamide, that inhibit the production of beta amyloid protein from amyloid precursor protein; capable of passing through the blood-brain barrier, used for treatment of Alzheimer's disease and Down's syndrome
01/28/2010US20100022585 Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
01/28/2010US20100022542 Compounds exhibiting thrombopoietin receptor agonism
01/28/2010US20100022525 Arginine Derivatives with NP-I Antagonistic Activity
01/28/2010CA2731869A1 Beta-and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
01/28/2010CA2728629A1 Adamantyl diamide derivatives and uses of same
01/27/2010EP2147923A1 Method for producing aromatic compound
01/27/2010EP1438298B1 Piperazine derivatives with ccr1 receptor antagonist activity
01/27/2010EP1303503B1 Aniline derivatives
01/27/2010CN100584840C Substituted heterocyclic compounds and uses thereof
01/27/2010CN100584839C Method for producing (S)-(+)-N,N-dimethyl-3-(1-naphthoxy)-3-(2-thienyl)propanamine
01/27/2010CN100584819C Substituted 4-aminocyclohexanol derivatives
01/27/2010CN100584459C Application of dehydroabietylamine thiourea catalyst in synthesizing chiral compound with high-antipodism both-hand control
01/27/2010CN100584323C Alpha-aminoamide derivatives useful in the treatment of lower urinary tract disorders
01/26/2010US7652168 Synthesis of taxol enhancers
01/26/2010US7652064 AMPA receptor potentiators
01/26/2010US7652063 For therapy of asthma, dysmenorrhea, osteoporosis, bone disorders, constipation, renal disorders, sexual dysfunction, baldness, acute hepatitis, bronchitis, burn, chronic obstructive respiratory diseases, Crohn's disease, digestive ulcer, hemophagous syndrome, hepatopathy, hypercytokinemia at dialysis
01/26/2010US7652020 novel hydantoin derivatives to inhibit matrix metalloproteinases (MMPs), a disintegrin and metalloproteases (ADAMs) and/or tumor necrosis factor alpha converting enzyme (TACE) and in so doing prevent the release of tumor necrosis factor alpha (TNF- alpha ); autoimmune diseases; side effect reduction
01/26/2010CA2338854C Nitric esters and nitrate salts of specific drugs
01/21/2010WO2010008081A1 Azo compound, azo pigment, pigment dispersion, color composition, inkjet recording ink, color composition for color filter, color filter, and method for preparing color composition for color filter
01/21/2010US20100016403 Use of d-serine derivatives for the treatment of anxiety disorders
01/21/2010US20100016383 4-(3,3-dihalo-allyloxy)phenol derivatives having pesticidal properties
01/21/2010US20100015053 Radiolabelled trp m8 receptor ligands
01/20/2010EP2144893A2 Tricyclic compounds as matrix metalloproteinase inhibitors
01/20/2010EP1654247B1 Alkynyl aryl carboxamides
01/20/2010EP1555257B1 Process for producing aromatic nitrile compound
01/20/2010EP1202961B1 Arylsulfonamido-substituted hydroxamic acid derivatives
01/20/2010CN101631783A Crystalline duloxetine hydrochloride
01/20/2010CN101628910A Novel micromolecule compound having high affinity with Abeta plaque as well as synthesis and application thereof
01/20/2010CN100582084C Hydrophobic polyamine analogs and methods for their use
01/19/2010US7649055 Method of producing highly functionalized 1,3-diamino-propan-2-ols from solid support
01/19/2010US7649012 Compounds, pharmaceutical compositions containing same, and methods of use for same
01/19/2010US7649005 Substituted benzylaminoalkylene heterocycles
01/19/2010US7649001 Fused benzene derivative and use
01/19/2010US7648738 for photopolymerization; photography, relief imaging; color filters
01/14/2010WO2010004957A1 Chiral iridium aqua complex and method for producing optically active hydroxy compound using the same
01/14/2010WO2010003942A2 Preparation of duloxetine and its pharmaceutically acceptable salts by the use of asymmetric transfer hydrogenation process
01/14/2010WO2009144263A3 PROCESS FOR OBTAINING 4-HYDROXY-6-METHYL-5, 6-DIHYDRO-4H-THIENO [2,3-b] THIOPYRAN-7, 7-DIOXIDE AND ITS ENANTIOMERS, AND APPLICATIONS THEREOF
01/14/2010WO2009140205A3 Therapeutic substituted cyclopentanes
01/14/2010US20100010012 Glutamate aggrecanase inhibitors
01/14/2010CA2730010A1 Inhibitors of janus kinases
01/13/2010EP2142511A2 Heterocyclyl-substituted-tetrahydro-naphthalen-amine derivatives, their preparation and use as medicaments
01/13/2010EP2142505A1 Sulfonamides and pharmaceutical compositions thereof
01/13/2010EP2142503A2 Process for the manufacture for non-steroidal anti-inflammatory agents and intermediates thereof
01/13/2010EP1685092B1 Asymmetric reductive amination of keto acid derivatives for producing amino acid derivatives
01/13/2010EP1575911B1 Biaromatic compounds which activate ppar-gamma type receptors and use thereof in cosmetic or pharmaceutical compositions
01/13/2010EP1144388B1 Acyl derivatives which treat vla-4 related disorders
01/13/2010CN101627026A Crystalline duloxetine hydrochloride
01/13/2010CN101624391A Thiophene derivatives as antiviral agents for flavivirus infection
01/13/2010CN100579975C Process for preparing duloxetine and intermediates for use therein
01/13/2010CN100579966C Method for manufacturing imidazole compounds and salts and pseudopolymorphs thereof
01/12/2010US7645890 Process for preparing duloxetine and intermediates for use therein
01/12/2010US7645799 thromboembolic and/or inflammatory disorders; 4-Aminomethyl-cyclohexanecarboxylic acid (1-biphenyl-3-yl-2-phenyl-ethyl)-amide; selective inhibitors of serine protease enzymes of the coagulation cascade and/or contact activation system; improved pharmacological properties, plasma kallikrein activity
01/12/2010US7645797 Gamma aminobutyric acid antagonist such as naphthylalanine; antiepileptic agents; antidepressants; anxiolytic agents; psychological disorders; neurodegenerative diseases; analgesics; drug withdrawal
01/12/2010US7645791 5-tert-Butyl-4-hydroxy-2-methyl-biphenyl-3-carboxylic acid (2-chloro-4-nitro-phenyl) -amide; chemical uncouplers like for the treatment of obesity
01/12/2010CA2407463C N-substituted peptidyl nitriles as cysteine cathepsin inhibitors
01/12/2010CA2391643C Gamma-hydroxy-2-(fluoroalkylaminocarbonyl)-1-piperazinepentanamides as hiv protease inhibitors
01/07/2010WO2010001821A1 Novel catechol derivative, pharmaceutical composition containing the same, use of the catechol derivative and use of the pharmaceutical composition
01/07/2010WO2010001126A1 Thiophene derivatives as kinase inhibitors
01/07/2010WO2010000504A1 Polymerisable compounds for making opto-electronic devices
01/07/2010WO2009034571A3 Selenophenes and selenophene-based polymers, their preparation and uses thereof
01/07/2010WO2009000533A8 Novel herbicides
01/07/2010WO2008151828A8 Novel microbiocides
01/07/2010US20100004467 Compounds comprising a linear series of five fused carbon rings, and preparation thereof
01/07/2010US20100004466 Benzothiophen-2-carbonylguanidine derivatives, preparation thereof, and pharmaceutical composition containing the same
01/07/2010US20100004339 Somatostatin Receptor 1 and/or 4 Selective Agonists and Antagonists
01/07/2010US20100004297 Novel hexafluoroisopropanol derivatives
01/07/2010US20100004241 Non-imidazole aryloxyalkylamines
01/07/2010US20100004130 Process for preparing substituted 2-alkoxycarbonyl-3-aminothiophenes
01/07/2010CA2729405A1 Novel catechol derivative, pharmaceutical composition containing the same, use of the catechol derivative, and use of the pharmaceutical composition
01/06/2010EP2139878A2 High refractive index monomers, compositions and uses thereof
01/06/2010EP2139851A2 Substituted amide derivatives
01/06/2010CN101622239A Process for the resolution of homocysteine-thiolactone
01/06/2010CN101619056A Benzothiophene alkanol piperazine derivatives and use thereof as antidepressant medicaments
01/05/2010US7642361 Thiophene and furan compounds
01/05/2010US7642272 Cannabinoid receptor ligands
01/05/2010US7642221 Substituted thien-3-yl-sulphonylamino(thio)carbonyl-triazoline(ethi)ones
01/05/2010US7641702 O-Aminophenol derivatives and colorants containing said compounds
01/05/2010CA2545999C 1,2-di(cyclic)substituted benzene compounds
01/05/2010CA2428255C Onium salts and the use therof as latent acids
12/2009
12/31/2009US20090326247 Method for producing 2-alkyl-3-aminothiophene derivative
12/31/2009US20090326038 Method for treating a immunology-related disease
1 ... 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 ... 329